Gf Fund Management Co. Ltd. Krystal Biotech, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 736 shares of KRYS stock, worth $92,036. This represents 0.0% of its overall portfolio holdings.
Number of Shares
736
Previous 604
21.85%
Holding current value
$92,036
Previous $94.6 Million
40.24%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding KRYS
# of Institutions
328Shares Held
24.3MCall Options Held
299KPut Options Held
97.6K-
Black Rock Inc. New York, NY3.95MShares$494 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.83MShares$353 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.73MShares$342 Million7.97% of portfolio
-
State Street Corp Boston, MA1.23MShares$153 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA954KShares$119 Million0.03% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.21B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...